{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T07:55:19Z","timestamp":1726041319848},"publisher-location":"New York, NY","reference-count":16,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493996698"},{"type":"electronic","value":"9781493996704"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-1-4939-9670-4_12","type":"book-chapter","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T12:03:15Z","timestamp":1565697795000},"page":"205-219","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Delivery of Antisense Oligonucleotides Mediated by a Hydrogel System: In Vitro and In Vivo Application in the Context of Spinal Cord Injury"],"prefix":"10.1007","author":[{"given":"Pedro M. D.","family":"Moreno","sequence":"first","affiliation":[]},{"given":"Teresa","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"Mar\u00edlia","family":"Torrado","sequence":"additional","affiliation":[]},{"given":"Isabel F.","family":"Amaral","sequence":"additional","affiliation":[]},{"given":"Ana P.","family":"P\u00eago","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,8,14]]},"reference":[{"key":"12_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/gels3010006","volume":"3","author":"Q Chai","year":"2017","unstructured":"Chai Q, Jiao Y, Yu X (2017) Hydrogels for biomedical applications: their characteristics and the mechanisms behind them. Gels 3:6\u201315. \n                    https:\/\/doi.org\/10.3390\/gels3010006","journal-title":"Gels"},{"key":"12_CR2","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1111\/j.1582-4934.2012.01603.x","volume":"16","author":"AP P\u00eago","year":"2012","unstructured":"P\u00eago AP, Kubinova S, Cizkova D et al (2012) Regenerative medicine for the treatment of spinal cord injury: more than just promises? J Cell Mol Med 16:2564\u20132582. \n                    https:\/\/doi.org\/10.1111\/j.1582-4934.2012.01603.x","journal-title":"J Cell Mol Med"},{"key":"12_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fncel.2015.00013","volume":"9","author":"OA Carballo-Molina","year":"2015","unstructured":"Carballo-Molina OA, Velasco I (2015) Hydrogels as scaffolds and delivery systems to enhance axonal regeneration after injuries. Front Cell Neurosci 9:13. \n                    https:\/\/doi.org\/10.3389\/fncel.2015.00013","journal-title":"Front Cell Neurosci"},{"key":"12_CR4","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1093\/nar\/gkp841","volume":"38","author":"CA Stein","year":"2010","unstructured":"Stein CA, Hansen JB, Lai J et al (2010) Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents. Nucleic Acids Res 38:e3. \n                    https:\/\/doi.org\/10.1093\/nar\/gkp841","journal-title":"Nucleic Acids Res"},{"key":"12_CR5","doi-asserted-by":"publisher","first-page":"7100","DOI":"10.1093\/nar\/gkq457","volume":"38","author":"EM Straarup","year":"2010","unstructured":"Straarup EM, Fisker N, Hedtj\u00e4rn M et al (2010) Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B mRNA and serum cholesterol in mice and non-human primates. Nucleic Acids Res 38:7100\u20137111. \n                    https:\/\/doi.org\/10.1093\/nar\/gkq457","journal-title":"Nucleic Acids Res"},{"key":"12_CR6","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nbt.3779","volume":"35","author":"ST Crooke","year":"2017","unstructured":"Crooke ST, Wang S, Vickers TA et al (2017) Cellular uptake and trafficking of antisense oligonucleotides. Nat Biotechnol 35:230\u2013237. \n                    https:\/\/doi.org\/10.1038\/nbt.3779","journal-title":"Nat Biotechnol"},{"key":"12_CR7","doi-asserted-by":"publisher","first-page":"72ra18","DOI":"10.1126\/scitranslmed.3001777","volume":"3","author":"MA Passini","year":"2011","unstructured":"Passini MA, Bu J, Richards AM et al (2011) Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy. Sci Transl Med 3:72ra18. \n                    https:\/\/doi.org\/10.1126\/scitranslmed.3001777","journal-title":"Sci Transl Med"},{"key":"12_CR8","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","volume":"74","author":"HB Kordasiewicz","year":"2012","unstructured":"Kordasiewicz HB, Stanek LM, Wancewicz EV et al (2012) Sustained therapeutic reversal of Huntington's disease by transient repression of Huntingtin synthesis. Neuron 74:1031\u20131044. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2012.05.009","journal-title":"Neuron"},{"key":"12_CR9","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nbt.3784","volume":"35","author":"O Khorkova","year":"2017","unstructured":"Khorkova O, Wahlestedt C (2017) Oligonucleotide therapies for disorders of the nervous system. Nat Biotechnol 35:249\u2013263. \n                    https:\/\/doi.org\/10.1038\/nbt.3784","journal-title":"Nat Biotechnol"},{"issue":"1","key":"12_CR10","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1146\/annurev-pharmtox-010818-021050","volume":"59","author":"C.I. Edvard Smith","year":"2019","unstructured":"Smith CIE, Zain R (2018) Therapeutic oligonucleotides: state of the art. Annu Rev Pharmacol Toxicol. \n                    https:\/\/doi.org\/10.1146\/annurev-pharmtox-010818-021050","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"12_CR11","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1002\/bit.22476","volume":"104","author":"PJ Johnson","year":"2009","unstructured":"Johnson PJ, Parker SR, Sakiyama-Elbert SE (2009) Controlled release of neurotrophin-3 from fibrin-based tissue engineering scaffolds enhances neural fiber sprouting following subacute spinal cord injury. Biotechnol Bioeng 104:1207\u20131214. \n                    https:\/\/doi.org\/10.1002\/bit.22476","journal-title":"Biotechnol Bioeng"},{"key":"12_CR12","doi-asserted-by":"publisher","first-page":"4447","DOI":"10.1016\/j.biomaterials.2010.02.018","volume":"31","author":"VR King","year":"2010","unstructured":"King VR, Alovskaya A, Wei DYT et al (2010) The use of injectable forms of fibrin and fibronectin to support axonal ingrowth after spinal cord injury. Biomaterials 31:4447\u20134456. \n                    https:\/\/doi.org\/10.1016\/j.biomaterials.2010.02.018","journal-title":"Biomaterials"},{"key":"12_CR13","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.expneurol.2014.04.008","volume":"257","author":"KG Sharp","year":"2014","unstructured":"Sharp KG, Yee KM, Steward O (2014) A re-assessment of long distance growth and connectivity of neural stem cells after severe spinal cord injury. Exp Neurol 257:186\u2013204. \n                    https:\/\/doi.org\/10.1016\/j.expneurol.2014.04.008","journal-title":"Exp Neurol"},{"key":"12_CR14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.omtn.2018.03.009","volume":"11","author":"PMD Moreno","year":"2018","unstructured":"Moreno PMD, Ferreira AR, Salvador D et al (2018) Hydrogel-assisted antisense LNA Gapmer delivery for in situ gene silencing in spinal cord injury. Mol Ther Nucleic Acids 11:393\u2013406. \n                    https:\/\/doi.org\/10.1016\/j.omtn.2018.03.009","journal-title":"Mol Ther Nucleic Acids"},{"key":"12_CR15","doi-asserted-by":"publisher","first-page":"20141224","DOI":"10.1098\/rsif.2014.1224","volume":"12","author":"LR Pires","year":"2015","unstructured":"Pires LR, Rocha DN, Ambrosio L, P\u00eago AP (2015) The role of the surface on microglia function: implications for central nervous system tissue engineering. J R Soc Interface 12:20141224\u201320141224. \n                    https:\/\/doi.org\/10.1098\/rsif.2014.1224","journal-title":"J R Soc Interface"},{"key":"12_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10856-017-5967-7","volume":"28","author":"LR Pires","year":"2017","unstructured":"Pires LR, Lopes CDF, Salvador D et al (2017) Ibuprofen-loaded fibrous patches-taming inhibition at the spinal cord injury site. J Mater Sci Mater Med 28:157. \n                    https:\/\/doi.org\/10.1007\/s10856-017-5967-7","journal-title":"J Mater Sci Mater Med"}],"container-title":["Methods in Molecular Biology","Oligonucleotide-Based Therapies"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-9670-4_12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T12:05:03Z","timestamp":1565697903000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-9670-4_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9781493996698","9781493996704"],"references-count":16,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-9670-4_12","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"14 August 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}